Several European regulators provide perspective on the use of mechanistic models in a complex generic drug development.
AI has the potential to greatly impact the regulatory affairs industry by helping with decision-making, detecting deficiencies in documentation, and automating tasks such as document generation and regulatory updates. It can also be used in collaboration with other companies and manufacturers to improve work efficiency and gain insights into drug content and public perception.
Today, the European Commission has proposed an extension of the transition period to certify medical devices.
We are providing our present services to our customers on this foundation. Therefore, we offer you scientific solutions with beneficial impact on your business processes to gain competitive advantages.
Billev Pharma East has been recently awarded the “Excellent SME Slovenia” certificate.
This certificate is issued by The Chamber of Commerce and Industry of Slovenia for SMEs with the intention to certify the trustworthiness of a specific company.
It serves as a reward for business excellence and outstanding business record.
Only the top 0.4% of top ranking SME companies can get it.